Publications

Abstract OT3-3-01: A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors.

Author(s): Gucalp A,  Morris PG,  Zhou XK,  Giri DD,  Iyengar NM,  Heckman-Stoddard BM,  Dunn B,  Garber JE,  Crew KD,  Hershman DL,  Nangia JR,  Cook ED,  Brown PH,  Dannenberg AJ,  Hudis CA

Journal: Cancer Res

Date: 2013 Dec 15

Major Program(s) or Research Group(s): CONSORTIA

PubMed ID:

PMC ID: not available

Abstract: